| Bobbie Sullivan Robertson, CRNP, FNP | |
|
3909 Mcfarland Blvd, Northport, AL 35476-2838 | |
| (205) 333-1993 | |
| (205) 333-0293 |
| Full Name | Bobbie Sullivan Robertson |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 3909 Mcfarland Blvd, Northport, Alabama |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265549851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1-058971 (Alabama) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1-058971 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bobbie Sullivan Robertson, CRNP, FNP 3909 Mcfarland Blvd, Northport, AL 35476-2838 Ph: (205) 333-1993 | Bobbie Sullivan Robertson, CRNP, FNP 3909 Mcfarland Blvd, Northport, AL 35476-2838 Ph: (205) 333-1993 |
News Archive
A new test could reliably detect early increases in prostate specific antigen (PSA) levels a biomarker commonly used to measure the recurrence of prostate cancer in men who have undergone prostate cancer treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.
Men face a greater risk of mortality following a fracture related to osteoporosis, a common disease where the bones become weak and brittle, according to new research presented today at the 2017 Annual Meeting of the American Academy of Orthopaedic Surgeons.
An international team of researchers have uncovered a drug-like compound that blocks a crucial inflammatory pathway, potentially paving the way for a new treatment for a host of diseases - including COVID-19.
Researchers have revealed a direct relationship between two specific antibodies and the severity of Alzheimer's disease symptoms, raising hopes that a diagnostic blood test for the devastating disorder is within reach.
Osaka University-led researchers identified differences in how three drugs bind to tumor necrosis factor, a key mediator of inflammatory disease. The team used sedimentation velocity analytical ultracentrifugation to investigate drug-target binding in a physiological environment and at clinically-relevant concentrations.
› Verified 1 days ago
Jacqueline Elaine White, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3105 31st Ave, Northport, AL 35476 Phone: 205-292-7230 | |
Lisa Colette Ryan, CRNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 4280 Watermelon Rd Ste 112, Northport, AL 35473 Phone: 205-750-0030 Fax: 205-750-0855 | |
Kara Lynne Pate, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5710 Watermelon Rd Ste 600, Northport, AL 35473 Phone: 205-345-6272 | |
William Jackson Steele Sr., MSN, CRNP, ACNPC-AG Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2700 Hospital Dr, Northport, AL 35476 Phone: 205-361-5291 | |
Haley Bolen, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1116 Mitt Lary Rd, Northport, AL 35475 Phone: 205-556-5634 | |
Dana Ofeldt, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9450 Earl Fields Cir, Northport, AL 35473 Phone: 205-393-6752 | |
Mrs. Amy Nicole Collins X, MSN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4280 Watermelon Rd Ste 111, Northport, AL 35473 Phone: 205-333-8554 Fax: 205-752-7696 |